My account:




  remember me

Enter   Register
Information
All rights reserved. Any reprinting of materials of the site is possible only with the written permission of administration and with a direct hyperlink to this site.

(#3 2018)



Ãîä:   2019   |   2018   |   2017   |   2016   |   2015   |   2014   |   2013   |   2012   |   2011   |   2010

Íîìåð:   4    |    3    |    2    |    1

METHODOLOGY

The Rules for Creation of Federal Drug Lists: Current State and Development Prospects

V. V. Omelyanovskiy2, 3, M. V. Sura1, 2, M. V. Avxentyeva1, 3, G. R. Khachatryan1, 2, 3

1. Center of Expertize and Quality Control of Medical Care, Ministry of Health of the Russian Federation, Moscow, Russia
2. Russian Presidential Academy of National Economy and Public Administration, Moscow, Russia
3. Financial Research Institute of the Ministry of Finance of the Russian Federation, Moscow, Russia


Omelyanovskiy V. V., Sura M. V., Avxentyeva M. V., Khachatryan G. R. The Rules for Creation of Federal Drug Lists: Current State and Development Prospects. Medical Technologies. Assessment and Choice. 2018; 2(32): 9–17.
INTERNATIONAL EXPERIENCE

The Principles of International Classification of Health Interventions of World Health Organization

I. V. Tyurina

Russian Presidential Academy of National Economy and Public Administration (RANEPA), Moscow, Russia
Center of Healthcare Quality Assessment and Control, Ministry of Health of the Russian Federation, Moscow, Russia


Tyurina I. V. The Principles of International Classification of Health Interventions of World Health Organization. Medical Technologies. Assessment and Choice. 2018; 3(33): 18–27.
MANAGEMENT IN HEALTH CARE

The Analysis of the Resources Used for the Activities of Outpatient Medical Organizations at the Level of Primary Medical Care

S. S. Budarin, Yu. V. Elbek

Research Institute of Health Care Organization and Medical Management, Moscow Department of Health, Moscow, Russia


Budarin S. S., Elbek Yu. V. The Analysis of the Resources Used for the Activities of Outpatient Medical Organizations at the Level of Primary Medical Care. Medical Technologies. Assessment and Choice. 2018; 3(33): 28–35.
Priorities for Maxillofacial Surgery Improvement in the Moscow Region

A. M. Sipkin, I. A. Kryazhinova, V. P. Lapshin

M. F. Vladimirsky Moscow Regional Research Clinical Institute (MONIKI), Moscow, Russia


Sipkin A. M., Kryazhinova I. A., Lapshin V. P. Priorities for Maxillofacial Surgery Improvement in the Moscow Region. Medical Technologies. Assessment and Choice. 2018; 3(33): 36–41.
Development of Knowledge Base Architecture for Clinical Decision Support System Based on Graph Database

K. V. Kiselev1, E. A. Noeva2, O. N. Vyborov2, A. V. Zorin2, A. V. Potekhina2, M. K. Osyaeva2, S. L. Shvyrev1, T. V. Martynyuk2, I. E. Chazova2, T. V. Zarubina1

1. Pirogov Russian National Research Medical University, Moscow, Russia
2. Federal state budget institution «National medical research center of cardiology» of the Ministry of healthcare of the Russian Federation, Moscow, Russia


Kiselev K. V., Noeva E. A., Vyborov O. N., Zorin A. V., Potekhina A. V., Osyaeva M. K., Shvyrev S. L., Martynyuk T. V., Chazova I. E., Zarubina T. V. Development of Knowledge Base Architecture for Clinical Decision Support System Based on Graph Database. Medical Technologies. Assessment and Choice. 2018; 3(33): 42–48.
Optimization of Costs of Inpatient Medical Care for Patients that Need Selective Antidotes to Muscle Relaxants after Abdominal Surgery

O. V. Obukhova1, I. V. Laricheva1, A. S. Brutova1, Ye. S. Yastrebova1, M. N. Zamyatin2

1. Federal Research Institute for Health Organization and Informatics, Moscow, Russia
2. N. I. Pirogov National Medical and Surgical Center, Moscow, Russia


Obukhova O. V., Laricheva I. V., Brutova A. S., Yastrebova Ye. S., Zamyatin M. N. Optimization of Costs of Inpatient Medical Care for Patients that Need Selective Antidotes to Muscle Relaxants after Abdominal Surgery. Medical Technologies. Assessment and Choice. 2018; 3(33): 50–61.
ORIGINAL RESEARCH

Pharmacoeconomic Evaluation of Enzalutamide, Abiraterone and Cabazitaxel for the Treatment of Post-Chemotherapy Patients with Metastatic Castration-Resistant Prostate Cancer

N. A. Avxentyev1, 2, E. V. Derkach2, A. S. Makarov3

1. Research Financial Institute of the Ministry of Finance of the Russian Federation, Moscow, Russia
2. Russian Presidential Academy of National Economy and Public Administration (RANEPA), Moscow, Russia
3. Association of Clinical Pharmacologists, Volgograd, Russia


Avxentyev N. A., Derkach E. V., Makarov A. S. Pharmacoeconomic Evaluation of Enzalutamide, Abiraterone and Cabazitaxel for the Treatment of Post-Chemotherapy Patients with Metastatic Castration-Resistant Prostate Cancer. Medical Technologies. Assessment and Choice. 2018; 3(33): 62–74.
Pharmacoeconomic Analysis of Drug Therapy of Chronic Obstructive Pulmonary Disease: Umeclidinium Bromide/Vilanterol Compared with other Combinations of Long-Acting β-Antagonists and Anticholinergics

A. G. Tolkushin1, N. L. Pogudin

1. Research Center for Clinical Studies and Medical Technology Assessment, Moscow Department of Health, Moscow, Russia
2. Independent Research Company «Razumniy Vybor», Moscow, Russia


Tolkushin A. G., Pogudin N. L. Pharmacoeconomic Analysis of Drug Therapy of Chronic Obstructive Pulmonary Disease: Umeclidinium Bromide/Vilanterol Compared with other Combinations of Long-Acting β-Antagonists and Anticholinergics. Medical Technologies. Assessment and Choice. 2018; 2(32): 75–88.
HISTORY

Mysteries of the Heart

I. V. Opimakh

Nauka Publishing House, Moscow, Russia

Opimakh I. V. Mysteries of the Heart. Medical Technologies. Assessment and Choice. 2018; 2(32): 89–94.
© 2019 Health Technology Assessment in Russia. Send a message         |